leflunomide has been researched along with Respiratory Tract Infections in 2 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Respiratory Tract Infections: Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment of rheumatoid arthritis (RA) has changed with the release of more efficient disease-modifying anti-inflammatory drugs (DMARDs) and biologicals, such as methotrexate, leflunomide and TNF blockers, respectively." | 4.82 | [Respiratory complications of new treatments for rheumatoid arthritis]. ( Lioté, H, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cano-Jiménez, E | 1 |
Vázquez Rodríguez, T | 1 |
Martín-Robles, I | 1 |
Castillo Villegas, D | 1 |
Juan García, J | 1 |
Bollo de Miguel, E | 1 |
Robles-Pérez, A | 1 |
Ferrer Galván, M | 1 |
Mouronte Roibas, C | 1 |
Herrera Lara, S | 1 |
Bermudo, G | 1 |
García Moyano, M | 1 |
Rodríguez Portal, JA | 1 |
Sellarés Torres, J | 1 |
Narváez, J | 1 |
Molina-Molina, M | 1 |
Lioté, H | 1 |
1 review available for leflunomide and Respiratory Tract Infections
Article | Year |
---|---|
[Respiratory complications of new treatments for rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide; Lung Diseases; Methotr | 2004 |
1 other study available for leflunomide and Respiratory Tract Infections
Article | Year |
---|---|
Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Cross-Sectional Studies | 2021 |